35661-60-0,MFCD10567377
Catalog No.:AA00I704

35661-60-0 | Fmoc-leu-oh

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5g
98%
in stock  
$6.00   $4.00
- +
10g
98%
in stock  
$7.00   $5.00
- +
25g
98%
in stock  
$14.00   $10.00
- +
100g
98%
in stock  
$47.00   $33.00
- +
500g
98%
in stock  
$175.00   $123.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00I704
Chemical Name:
Fmoc-leu-oh
CAS Number:
35661-60-0
Molecular Formula:
C21H23NO4
Molecular Weight:
353.4116
MDL Number:
MFCD10567377
SMILES:
CC(C[C@@H](C(=O)O)NC(=O)OCC1c2ccccc2c2c1cccc2)C
Properties
Properties
 
BP:
559.8 °C at 760 mmHg  
Form:
Solid  
MP:
152-156 °C(lit.);  
Refractive Index:
-25 ° (C=1, DMF)  
Storage:
Room Temperature;  

Computed Properties
 
Complexity:
484  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
26  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
7  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
4.4  

Literature

Title: Study on cow ghee versus soybean oil on 7,12-dimethylbenz(a)-anthracene induced mammary carcinogenesis & expression of cyclooxygenase-2 & peroxisome proliferators activated receptor-γ in rats.

Journal: The Indian journal of medical research 20110501

Title: Comparative dynamics of leucine methyl groups in FMOC-leucine and in a protein hydrophobic core probed by solid-state deuteron nuclear magnetic resonance over 7-324 K temperature range.

Journal: The journal of physical chemistry. B 20101209

Title: The 20S proteasome splicing activity discovered by SpliceMet.

Journal: PLoS computational biology 20100601

Title: Hydrogelation and self-assembly of Fmoc-tripeptides: unexpected influence of sequence on self-assembled fibril structure, and hydrogel modulus and anisotropy.

Journal: Langmuir : the ACS journal of surfaces and colloids 20100406

Title: Suppression of tumor formation by a cyclooxygenase-2 inhibitor and a peroxisome proliferator-activated receptor gamma agonist in an in vivo mouse model of spontaneous breast cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20080801

Title: The PPARgamma agonist FMOC-L-leucine protects both mature and immature brain.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20080101

Title: 'Striking the Right Balance' in Targeting PPARgamma in the Metabolic Syndrome: Novel Insights from Human Genetic Studies.

Journal: PPAR research 20070101

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Title: Characterization of compound mechanisms and secondary activities by BioMAP analysis.

Journal: Journal of pharmacological and toxicological methods 20060101

Title: Self-assembly of small molecules affords multifunctional supramolecular hydrogels for topically treating simulated uranium wounds.

Journal: Chemical communications (Cambridge, England) 20050921

Title: Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma.

Journal: Cancer research 20040201

Title: PPAR-gamma: a thrifty transcription factor.

Journal: Nuclear receptor signaling 20030101

Title: Effect of NPC-15199 on Ca2+ levels in renal tubular cells.

Journal: The Chinese journal of physiology 20020930

Title: PPARgamma, an X-ceptor for Xs.

Journal: Annals of the New York Academy of Sciences 20020601

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:35661-60-0 Molecular Formula|35661-60-0 MDL|35661-60-0 SMILES|35661-60-0 Fmoc-leu-oh
Catalog No.: AA00I704
35661-60-0,MFCD10567377
35661-60-0 | Fmoc-leu-oh
Pack Size: 5g
Purity: 98%
in stock
$6.00 $4.00
Pack Size: 10g
Purity: 98%
in stock
$7.00 $5.00
Pack Size: 25g
Purity: 98%
in stock
$14.00 $10.00
Pack Size: 100g
Purity: 98%
in stock
$47.00 $33.00
Pack Size: 500g
Purity: 98%
in stock
$175.00 $123.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00I704
Chemical Name: Fmoc-leu-oh
CAS Number: 35661-60-0
Molecular Formula: C21H23NO4
Molecular Weight: 353.4116
MDL Number: MFCD10567377
SMILES: CC(C[C@@H](C(=O)O)NC(=O)OCC1c2ccccc2c2c1cccc2)C
Properties
BP: 559.8 °C at 760 mmHg  
Form: Solid  
MP: 152-156 °C(lit.);  
Refractive Index: -25 ° (C=1, DMF)  
Storage: Room Temperature;  
Complexity: 484  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 1  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 26  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 7  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 4.4  
Literature fold

Title: Study on cow ghee versus soybean oil on 7,12-dimethylbenz(a)-anthracene induced mammary carcinogenesis & expression of cyclooxygenase-2 & peroxisome proliferators activated receptor-γ in rats.

Journal: The Indian journal of medical research20110501

Title: Comparative dynamics of leucine methyl groups in FMOC-leucine and in a protein hydrophobic core probed by solid-state deuteron nuclear magnetic resonance over 7-324 K temperature range.

Journal: The journal of physical chemistry. B20101209

Title: The 20S proteasome splicing activity discovered by SpliceMet.

Journal: PLoS computational biology20100601

Title: Hydrogelation and self-assembly of Fmoc-tripeptides: unexpected influence of sequence on self-assembled fibril structure, and hydrogel modulus and anisotropy.

Journal: Langmuir : the ACS journal of surfaces and colloids20100406

Title: Suppression of tumor formation by a cyclooxygenase-2 inhibitor and a peroxisome proliferator-activated receptor gamma agonist in an in vivo mouse model of spontaneous breast cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research20080801

Title: The PPARgamma agonist FMOC-L-leucine protects both mature and immature brain.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie20080101

Title: 'Striking the Right Balance' in Targeting PPARgamma in the Metabolic Syndrome: Novel Insights from Human Genetic Studies.

Journal: PPAR research20070101

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Title: Characterization of compound mechanisms and secondary activities by BioMAP analysis.

Journal: Journal of pharmacological and toxicological methods20060101

Title: Self-assembly of small molecules affords multifunctional supramolecular hydrogels for topically treating simulated uranium wounds.

Journal: Chemical communications (Cambridge, England)20050921

Title: Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma.

Journal: Cancer research20040201

Title: PPAR-gamma: a thrifty transcription factor.

Journal: Nuclear receptor signaling20030101

Title: Effect of NPC-15199 on Ca2+ levels in renal tubular cells.

Journal: The Chinese journal of physiology20020930

Title: PPARgamma, an X-ceptor for Xs.

Journal: Annals of the New York Academy of Sciences20020601

Building Blocks More >
364372-16-7
364372-16-7
Toluene-4-sulfonate5-amino-1,2,3,3-tetramethyl-3h-indolium
AA00I756 | MFCD06654910
375368-84-6
375368-84-6
5-Chloro-2-fluoro-3-methylpyridine
AA00I7BI | MFCD03095094
383127-62-6
383127-62-6
2-(4-Methylbenzyl)pyrrolidine
AA00I7GS | MFCD02663496
392-13-2
392-13-2
5-Fluoro-3-methylindole
AA00I7NR | MFCD03095377
401892-80-6
401892-80-6
3-(Pentafluorosulfanyl)benzaldehyde
AA00I7T7 | MFCD03788517
412293-98-2
412293-98-2
1-(Phenylsulfonyl)piperazine hydrochloride
AA00I7ZQ | MFCD08444040
4235-95-4
4235-95-4
1,2-Dioleoyl-sn-glycero-3-phosphocholine
AA00I84K | MFCD00135191
439948-91-1
439948-91-1
(4S)-2,2-Dioxido-4-methyl-1,2,3-oxathiazolidine, n-boc protected
AA00I8AW | MFCD28122917
4569-45-3
4569-45-3
9,9-Dimethylfluorene
AA00I8GD | MFCD00009330
477-90-7
477-90-7
Bergenin
AA00I8M1 | MFCD00167248
Submit
© 2017 AA BLOCKS, INC. All rights reserved.